BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18037589)

  • 1. Clofarabine acts as radiosensitizer in vitro and in vivo by interfering with DNA damage response.
    Cariveau MJ; Stackhouse M; Cui XL; Tiwari K; Waud W; Secrist JA; Xu B
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):213-20. PubMed ID: 18037589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
    Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
    Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response.
    Chu PM; Chiou SH; Su TL; Lee YJ; Chen LH; Chen YW; Yen SH; Chen MT; Chen MH; Shih YH; Tu PH; Ma HI
    Radiat Oncol; 2011 Jan; 6():7. PubMed ID: 21244709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
    Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
    Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired S-phase arrest in acute myeloid leukemia cells with a FLT3 internal tandem duplication treated with clofarabine.
    Seedhouse C; Grundy M; Shang S; Ronan J; Pimblett H; Russell N; Pallis M
    Clin Cancer Res; 2009 Dec; 15(23):7291-8. PubMed ID: 19934300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
    Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
    Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy.
    Quanz M; Berthault N; Roulin C; Roy M; Herbette A; Agrario C; Alberti C; Josserand V; Coll JL; Sastre-Garau X; Cosset JM; Larue L; Sun JS; Dutreix M
    Clin Cancer Res; 2009 Feb; 15(4):1308-16. PubMed ID: 19190126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
    Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
    Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
    Chattopadhyay N; Cai Z; Kwon YL; Lechtman E; Pignol JP; Reilly RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):81-91. PubMed ID: 23160926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine.
    Oleinick NL; Biswas T; Patel R; Tao M; Patel R; Weeks L; Sharma N; Dowlati A; Gerson SL; Fu P; Zhang J; Machtay M
    Radiother Oncol; 2016 Nov; 121(2):335-341. PubMed ID: 27838149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
    Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
    Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine: past, present, and future.
    Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
    Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
    Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
    Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
    Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
    Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog.
    Huang G; Wang H; Yang LX
    Anticancer Res; 2010 Mar; 30(3):937-44. PubMed ID: 20393017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide.
    Olsson A; Sheng Y; Kjellén E; Pero RW
    Carcinogenesis; 1995 May; 16(5):1029-35. PubMed ID: 7767961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ; Schneider P; Pieters R; Stam RW
    Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.